Dried blood spot HIV-1 RNA quantifcation: A useful tool for viral load monitoring among HIV-infected individuals in India

Indian Journal of Medical Research

Volumn 136, Issue 6, 2012, Pages 956-962

  Neogi, Ujjwal ^a   Gupta, Soham ^a   Rodridges, Rashmi ^a   Sahoo, Pravat Nalini ^a   Rao, Shwetha D ^a   Rewari, Bharat B ^b   Shastri, Suresh ^b   De Costa, Ayesha ^c   Shet, Anita ^a  

^a ST JOHN'S NATIONAL ACADEMY OF HEALTH SCIENCES   (India)

^b National AIDS Control Organization   (India)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Dried blood spot; HIV; India; Public health; Resource limited settings; Viral load

Indexed keywords

VIRUS RNA;

ADULT; ARTICLE; CONTROLLED STUDY; COST; DIAGNOSTIC TEST ACCURACY STUDY; DRIED BLOOD SPOT TESTING; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MAJOR CLINICAL STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; VIREMIA; VIRUS LOAD; BLOOD; ECONOMICS; EVALUATION STUDY; GENETICS; HIV INFECTIONS; INDIA; ISOLATION AND PURIFICATION; MIDDLE AGED; PROCEDURES;

ADULT; DRIED BLOOD SPOT TESTING; HIV INFECTIONS; HIV-1; HUMANS; INDIA; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; RNA, VIRAL; VIRAL LOAD;

EID: 84873197329     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. People alive and on ART, National AIDS Control Organization, May 2011. Available from: http://www.nacoonline.org/upload/HIV%20data/Patients%20%20alive%20on%20ART%20_May%202011.pdf, accessed on June 1, 2011.
2. Ledergerber B, Lundgren JD, Walker AS. Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes. Lancet 2004; 364: 51-62.
3. Bahrani A, Ramaswamy R, Oldfeld EC. Effects of virologic rebound on CD4 cell counts. Clin Infect Dis 2001; 32: 1231-2.
4. Marconi A, Balestrieri M, Comastri G, Pulvirenti FR, Gennari W, Tagliazucchi S, et al. Evaluation of the Abbott real-time HIV-1 quantitative assay with dried blood spot specimens. Clin Microbiol Infect 2008; 15: 93-7.
5. Garrido C, Zahonero N, Corral A, Arredondo M, Soriano V, Mendoza C. Correlation between human immunodefciency virus type 1 (HIV-1) RNA measurements obtained with dried blood spots and those obtained with plasma by use of Nuclisens EasyQ HIV-1 and Abbott RealTime HIV load tests. J Clin Microbiol 2009; 47: 1031-6.
6. Mbida AD, Sosso S, Flori P, Saoudin H, Lawrence P, Monny-Lobé M, et al. Measure of viral load by using the Abbott RealTime HIV-1 assay on dried blood and plasma spot specimens collected in 2 rural dispensaries in Cameroon. J Acquir Immune Defc Syndr 2009; 52: 9-16.
7. Brambilla D, Jennings C, Aldrovandi G, Bremer J, Comeau AM, Cassol SA, et al. Multicenter evaluation of use of dried blood and plasma spot specimens in quantitative assays for human immunodefciency virus RNA: measurement, precision and RNA stability. J Clin Microbiol 2003; 41: 1888-93.
8. Johannessen A, Garrido C, Zahonero N, Sandvik L, Naman E, Kivuyo SL, et al. Dried blood spots perform well in viral load monitoring of patients who received antiretroviral treatment in rural Tanzania. Clin Infect Dis 2009; 49: 976-81.
9. Comeau AM, Pitt J, Hillyer GV, Landesman S, Bremer J, Chang BH, et al. Early detection of human immunodefciency virus on dried blood spot specimens: sensitivity across serial specimens. Women and Infants Transmission Study Group. J Pediatr 1996; 129: 111-8.
10. Bertagnolio S, Derdelinckx I, Parker M, Fitzgibbon J, Fleury H, Peeters M, et al. World Health organization/HIVResNet Drug Resistance Laboratory Strategy. Antiviral Ther 2008; 13 (Suppl 2): 49-57.
11. Waters L, Kambugu A, Tibenderana H, Meya D, John L, Mandalia S, et al. Evaluation of flter paper transfer of whole blood and plasma samples for quantifying HIV RNA in subjects on antiretroviral therapy in Uganda. J Acquire Immune Defc Syndr 2007; 46: 590-3.
12. Kane CT, Ndiaye HD, Diallo S, Ndiaye I, Wade AS, Diaw PA, et al. Quantitation of HIV-1 RNA in dried blood spots by the real-time NucliSENS EasyQ HIV-1 assay in Senegal. J Virol Methods 2008; 148: 291-5.
13. De Costa A, Shet A, Kumarasamy N, Ashorn P, Eriksson B, Bogg L, et al. Design of a randomized trial to evaluate the infuence of mobile phone reminders on adherence to frst line antiretroviral treatment in South India - the HIVIND study protocol. BMC Med Res Methodol 2010; 10: 25.
14. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 307: 307-10.
15. Technical Brief on HIV Viral Load Technologies (June 2010). Available from: http://www.who.int/hiv/topics/treatment/tech_brief_20100601_en.pdf, accessed on March 18, 2011.
16. McCabe ER, Huang SZ, Seltzer WK, Law ML. DNA microextraction from dried blood spots on flter paper blotters: potential applications to newborn screening. Hum Genet 1987; 75: 213-6.
17. Hoff R, Berardi VP, Weiblen BJ, Mahoney-Trout L, Mitchell ML, Grady GF. Seroprevalence of human immunodefciency virus among childbearing women. Estimation by testing samples of blood from newborns. N Engl J Med 1988; 318: 525-30.
18. Cassol SA, Lapointe N, Salas T, Hankins C, Arella M, Fauvel M, et al. Diagnosis of vertical HIV-1 transmission using the polymerase chain reaction and dried blood spot specimens. J Acquir Immune Defc Syndr 1992; 5: 113-9.
19. WHO manual for HIV drug resistance testing using dried blood spot specimen, March 2010. Available from: http://www.who.int/hiv/topics/drugresistance/dbs_protocol.pdf, accessed on March 12, 2011.
20. Fransen K, Mortier D, Heyndrickx L, Verhofstede C, Janssens W, Van der Groen G. Isolation of HIV-1 RNA from plasma: evaluation of seven different methods for extraction (part two). J Virol Methods 1998; 76: 153-7.
21. Ssebugenyi I, Kizza A, Mpoza B, Aluma G, Boaz I, Newell K, et al. Comparison of the Abbott m2000 HIV-1 Real-Time and Roche AMPLICOR Monitor v1.5 HIV-1 assays on plasma specimens from Rakai, Uganda. Int J STD & AIDS 2011; 22: 373-5.
22. Prosperi MC, Mackie N, Di Giambenedetto S, Zazzi M, Camacho R, Fanti I, et al. Detection of drug resistance mutations at low plasma HIV-1 RNA load in a European multicentre cohort study. J Antimicrob Chemother 2011; 66: 1886-96.
23. Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach.- 2010 rev. July 2010. Available from: http://whqlibdoc.who.int/publications/2010/9789241599764_eng.pdf, accessed on July 11, 2011.
24. Johannessen A. Dried blood spots in HIV monitoring: applications in resource-limited settings. Bioanalysis 2010; 2: 1893-908.
25. Hamers RL, Smit PW, Stevens W, Schuurman R, Rinke de Wit TF. Dried fuid spots for HIV type-1 viral load and resistance genotyping: a systematic review. Antivir Ther 2009; 14: 619-29.
26. Bertagnolio S, Parkin NT, Jordan M, Brooks J, García-Lerma JG. Dried blood spots for HIV-1 drug resistance and viral load testing: A review of current knowledge and WHO efforts for global HIV drug resistance surveillance. AIDS Rev 2010; 12: 195-208.
27. Pirillo MF, Recordon-Pinson P, Andreotti M, Mancini MG, Amici R, Giuliano M. Quantifcation of HIV-RNA from dried blood spots using the Siemens VERSANT HIV-1 RNA (kPCR) assay. J Antimicrob Chemother 2011; 66: 2823-6.
28. National AIDS Control Program, Phase III (2006-2011), November 2006. Available from: www.nacoonline.org, accessed on July 13, 2011.